Identification of LL-37 as a Molecular Target for Boswellic Acids
1
Pharmaceutical Institute, Eberhard Karls University, Auf der Morgenstelle 8, 72076, Tübingen, Germany
2
Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(7), 238; https://doi.org/10.3797/scipharm.oephg.21.PO-39
Submission received: 16 April 2009
/
Accepted: 16 April 2009
/
Published: 16 April 2009
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
Gum resin extracts of Boswellia serrata have been traditionally applied in folk medicine for the treatment of various inflammatory diseases. Analyses of these extracts identified a group of pentacyclic triterpenes, the boswellic acids (BAs), as active principles that might be responsible for some of the observed anti-inflammatory effects.[...]
Share and Cite
MDPI and ACS Style
HENKEL, A.; TAUSCH, L.; WERZ, O. Identification of LL-37 as a Molecular Target for Boswellic Acids. Sci. Pharm. 2009, 77, 238. https://doi.org/10.3797/scipharm.oephg.21.PO-39
AMA Style
HENKEL A, TAUSCH L, WERZ O. Identification of LL-37 as a Molecular Target for Boswellic Acids. Scientia Pharmaceutica. 2009; 77(Posters (PO)):238. https://doi.org/10.3797/scipharm.oephg.21.PO-39
Chicago/Turabian StyleHENKEL, A., L. TAUSCH, and O. WERZ. 2009. "Identification of LL-37 as a Molecular Target for Boswellic Acids" Scientia Pharmaceutica 77, Posters (PO): 238. https://doi.org/10.3797/scipharm.oephg.21.PO-39
